Results 61 to 70 of about 1,650 (186)

Organoid Models to Study Human Infectious Diseases

Cell Proliferation, Volume 58, Issue 11, November 2025.
Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu, Dan Chen, Xinzhi Yang, Liuliu Yang, Yuling Han   +4 more
wiley   +1 more source

FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET QUETIAPINE FUMARATE BY USING NATURAL POLYMER [PDF]

, 2018
The purpose of present study was to develop once a day sustained release matrix tablet of Quetiapine Fumarate by using natural polymer viz. Xanthan gum and isolated fenugreek mucilage.
Priya Patil*and Vijay R. Mahajan
core   +1 more source

Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease‐Modifying Treatments for Multiple Sclerosis

European Journal of Neurology, Volume 32, Issue 11, November 2025.
ABSTRACT Background Regenerative strategies in progressive multiple sclerosis (MS) pose a significant unmet need. Combining immunomodulatory treatment with remyelinating interventions to target the complex underlying pathogenesis appeals as the next frontier in MS therapeutic developments.
Anna‐Victoria De Keersmaecker, Eline van Doninck, Inez Wens, Yousra El Ouaamari, Veronica Popescu, Guy Laureys, Melissa Cambron, Miguel D'Haeseleer, Lander Willem, Judith Derdelinckx, Tatjana Reynders, Barbara Willekens   +11 more
wiley   +1 more source

Is Hearing Impairment Associated With Specific Behavioural and Psychological Symptoms of Dementia in Japanese Older Adults Attending a Memory Clinic?

Psychogeriatrics, Volume 25, Issue 5, September 2025.
ABSTRACT Background Behavioural and psychological symptoms of dementia (BPSD), encompassing disturbances in perception, thought, mood and behaviour, are prevalent among individuals with dementia and can substantially affect their quality of life. Although prior research has suggested that hearing impairment (HI) may exacerbate BPSD due to communication
Saki Tanaka, Ryo Katayose, Teruaki Kawasaki, Ichiro Akiguchi, Mihoko Ogita   +4 more
wiley   +1 more source

Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach

, 2021
In this study, transfer from lab-scale non-continuous production to pilot-scale continuous production of orodispersible films was provided using solvent casting method under the framework of quality by design.
Ozsoy, Yildiz, Oztas, Ezgi, Cevher, Erdal, Bulbul, Ece Ozcan, Mesut, Burcu   +4 more
core   +1 more source

Chronic Quetiapine Administration Has a Therapeutic Effect on Anxiety and Depression‐Like Behavior in a Chronic Unpredictable Mild Stress (CUMS) Rat Model

Brain and Behavior, Volume 15, Issue 8, August 2025.
This article presents the effects of chronic quetiapine administration on anxiety and depression with and without chronic unpredictable mild stress disorder (CUMS) in female adult Wistar albino rats using behavioral analyses. Quetiapine effectively mitigates depression‐ and anxiety‐like behaviors induced by chronic stress, supporting its potential ...
Esra Komanovalı, Burcu Çevreli, Öznur Özge Özcan   +2 more
wiley   +1 more source

Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route

Saudi Pharmaceutical Journal, 2017
The problem of inadequate oral bioavailability of Quetiapine Fumarate, a lipophilic drug used for schizophrenia, due to hepatic metabolism and repulsion by brain barrier was attempted in this study. Combination of two approaches, viz.
Pratik Upadhyay, Jatin Trivedi, Kilambi Pundarikakshudu, Navin Sheth   +3 more
doaj   +1 more source

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder

, 2013
BACKGROUND: Patients with treatment-resistant major depressive disorder (MDD) remain a common clinical challenge. METHODS: This 6-week, randomised, open-label, rater-blinded trial evaluated once-daily extended-release quetiapine fumarate (quetiapine XR;
DELL'OSSO, LILIANA, Jürgen Köhler, Stuart A. Montgomery, William Pitchot, Michael Bauer, Eva Dencker Vansvik, Siegfried Kasper, Leif Jørgensen   +7 more
core   +1 more source

HPLC analysis of quetiapine-Fig. S3

, 2020
Chromatograms of placebo, quetiapine fumarate and extemporaneous formulations F1A and F1B stored at 4°C and 30±2°C/65±5 ...
Nantana Nuchtavorn (8701092)
core   +1 more source

Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial

Archives of Academic Emergency Medicine, 2018
Introduction: About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.
Saeed Reza Ghanbarizadeh, Hossein Dinpanah, Reza Ghasemi, Yaser Salahshour, Samaneh Sardashti, Mostafa Kamali, Seyed Reza Khatibi   +6 more
doaj   +1 more source